Toloza MJ - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Expression dynamics of the immune mediators ARG1, TBET, CIITA, IL10 and TGFB1 in chronic myeloid leukaemia patients during the first year of imatinib therapy.

Toloza MJ, Bestach Y, Lincango-Yupanki M, Bordone J, Mariano R, Tarqui M, Pérez M, Aranguren PN, Enrico A, Larripa IB, Belli CB. Toloza MJ, et al. Gene. 2022 Mar 1;813:146110. doi: 10.1016/j.gene.2021.146110. Epub 2021 Dec 10. Gene. 2022. PMID: 34902507

The dynamic of TNF and IL6 gene expression in chronic myeloid leukemia patients reveals early responders to imatinib.

Bestach Y, Toloza MJ, Ferri C, Larripa I, Belli C. Bestach Y, et al. Among authors: toloza mj. Leuk Res. 2019 Nov;86:106221. doi: 10.1016/j.leukres.2019.106221. Epub 2019 Sep 4. Leuk Res. 2019. PMID: 31520987 No abstract available.

Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia.

Toloza MJ, Lincango M, Camacho MF, Ledesma MM, Enrico A, Moiraghi B, Tosin F, Mariano R, Pérez M, Aranguren PN, Riva ME, Larripa IB, Belli CB. Toloza MJ, et al. Ann Hematol. 2024 Dec;103(12):5249-5260. doi: 10.1007/s00277-024-06074-3. Epub 2024 Nov 7. Ann Hematol. 2024. PMID: 39505795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters